The Utility of CT Coronary Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention.

Autor:	Yassin F; Department of Cardiology, Birmingham City Hospital Birmingham, UK., Khan J; Department of Cardiology, Birmingham City Hospital Birmingham, UK.; Aston Medical School, University of Aston Birmingham, UK., Mozid A; Department of Cardiology, Leeds General Infirmary Leeds, UK., Connolly D; Department of Cardiology, Birmingham City Hospital Birmingham, UK.; Aston Medical School, University of Aston Birmingham, UK.; University of Birmingham Birmingham, UK., Sharma V; Department of Cardiology, Birmingham City Hospital Birmingham, UK.; University of Birmingham Birmingham, UK.
Jazyk:	angličtina
Zdroj:	European cardiology [Eur Cardiol] 2023 Aug 18; Vol. 18, pp. e48. Date of Electronic Publication: 2023 Aug 18 (Print Publication: 2023).
DOI:	10.15420/ecr.2022.61
Abstrakt:	Chronic total occlusion (CTO) of the coronary arteries is a relatively common finding in routine coronary angiography. Of late, there has been considerable improvement in the success rate of percutaneous intervention for coronary CTO, attributed to technological advancement and skills development. CT coronary angiogram (CTCA) is a simple, non-invasive, and cost-effective test that aids in the diagnosis and management of coronary artery disease, including CTOs. The development of multi-slice CT and the use of 3D volume rendering images has revolutionised the diagnostic abilities of CTCA, with improvements in imaging quality and detailed anatomical and morphological characterisation of the plaque disease. In CTO percutaneous intervention, CTCA is used in pre-procedural planning, applying scoring systems to predict the likely success of the intervention as well as the post-procedural evaluation and follow-up. This review examines the different uses of CTCA in CTO intervention, its impact on successful recanalisation and the areas for future consideration. Competing Interests: Disclosure: DC and VS are on the European Cardiology Review editorial board; this did not influence peer review. All other authors have no conflicts of interest to declare. (Copyright © The Author(s), 2023. Published by Radcliffe Group Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu